MoreLife USA is expanding ethical, scalable plasma donation infrastructure to support life-saving therapies—especially in underserved rural communities.
Operates a growing network of FDA-licensed plasma donation centers focused on rural and underserved markets where access to healthcare resources remains critically limited.
Targeting underserved communities with population densities optimal for sustainable operations
Transparent compensation, professional medical standards, and community-first approach
Proven operational model designed for rapid, sustainable expansion across multiple states
Targeting 150+ locations across underserved rural markets in 12 states
Plasma demand continues to rise as medical innovations expand treatment options and global healthcare needs increase
US Plasma Market
Rigorous medical protocols and FDA compliance in every donation process.
Annual Growth
Plasma demand growing faster than donor supply
Patients Depend
Americans rely on plasma-derived therapies annually
Rural Market Gap
Underserved communities without accessible centers
Aging Population:
Increasing demand for immunoglobulin therapies
Medical Innovation:
New plasma-based treatments entering the market
Supply Shortage:
Growing gap between donor supply and clinical demand
Rural Access Gap:
Massive underserved market with limited competition
First-Mover Position:
Establishing presence before major competitors
Lower Operating Costs:
Rural markets offer favorable real estate and labor economics
Community Integration:
Strong local relationships and donor loyalty
Scalable Model:
Proven operations framework ready for rapid expansion
FDA-licensed centers collect plasma from compensated donors through safe, automated processes
Full FDA compliance and AABB accreditation ensure highest quality and safety standards
Plasma sold to pharmaceutical manufacturers who produce life-saving therapies
Annual Revenue per Center
EBITDA Margins at Scale
ROI Target Timeframe
Bringing essential plasma collection infrastructure to underserved rural communities
Creating local economic opportunities and reducing healthcare deserts
Employing medical professionals and support staff in rural areas
Transparent donor compensation and professional medical standards
Compliance Rate
85% of rural communities lack access to plasma donation centers, forcing residents to travel hours to participate in this essential healthcare contribution. This creates a dual problem: reduced plasma supply and limited economic opportunities.
“Our expansion isn’t just about market opportunity—it’s about ensuring every American, regardless of zip code, has access to participate in life-saving healthcare contributions.”
— Dr. Sarah Mitchell, Chief Medical Officer
$8.5B US plasma market with growing demand
$11.2B market with 7-9% CAGR
$14.5B+ as therapies expand globally
By 2030, 1 in 6 people worldwide will be aged 60+, driving demand for immunoglobulin therapies and chronic disease treatments
New plasma-based therapies in development for COVID-19, Alzheimer's, and rare genetic disorders expand market applications
Only 2% of eligible Americans donate plasma, creating structural supply shortages that support premium pricing
Our advisory board includes former FDA officials, healthcare policy experts, and industry veterans who provide strategic guidance on expansion, compliance, and market positioning.
Comprehensive pitch deck with financials, market analysis, and growth strategy
One-page overview of business model, opportunity, and key metrics
Reach out to our investor relations team for detailed discussions
Our investor relations team is available to answer questions, provide additional materials, and schedule meetings with leadership
Investment opportunities are available to accredited investors only. All materials subject to NDA and confidentiality agreements.
35%+ EBITDA margins with clear path to profitability
Expanding healthcare access to underserved communities
Scalable operations with experienced leadership team
